Mild therapeutic hypothermia alleviated myocardial ischemia/reperfusion injury via targeting SLC25A10 to suppress mitochondrial apoptosis

Author:

Ma Senlin1,Song Yun1,Xu Yanxin1,Wang Chao1,Yang Yifan1,Zheng Yanchao1,Lu Qiuxin1,Chen Qingjiang1,Wu Jian1,Wang Bin1ORCID,Chen Mingquan1

Affiliation:

1. Huashan Hospital Fudan University

Abstract

Abstract Purpose Myocardial ischemia/reperfusion injury (MI/RI) is identified as a severe vascular emergency and the treatment strategy of MI/RI still needs further improvement. The present study aimed to investigate the potential effects of mild therapeutic hypothermia (MTH) on MI/RI and underlying mechanisms. Methods In in vivoexperiments, rats were subjected to ischemia/reperfusion (I/R) injury with MTH treatment. Cardiac function, myocardial injury, and mitochondrial apoptosis pathway were determined. Total proteins of rat myocardium were obtained for LC-MS/MS analysis. In in vitro experiments, AC16 cardiomyocytes were subjected to hypoxia and reoxygenation (H/R) with MTH treatment. The effects of MTH treatment on myocardial cell injury, mitochondrial dysfunction, mitochondrial apoptosis pathway induced by H/R were analyzed. Results In I/R rats, MTH treatment significantly improved the cardiac function and myocardial injury, and inhibited the activation of mitochondrial apoptosis pathway. Meanwhile, MTH treatment also attenuated myocardial infarction size and alleviated myocardial structural damage induced by I/R. The results of proteomics identified SLC25A10 as the main target of MTH treatment. Consistently, the expressions of SLC25A10 in I/R rat myocardium and H/R cardiomyocytes were significantly suppressed, which was effectively reversed by MTH treatment. In H/R cardiomyocytes, MTH treatment significantly improved cell injury, mitochondrial dysfunction, and inhibited the activation of mitochondrial apoptosis pathway. As expected, SLC25A10 deletion partially abolished the protective effects of MTH treatment on H/R cardiomyocytes. Conclusions These findings suggested that MTH treatment could protect against MI/RI by modulating SLC25A10 expression to suppress mitochondrial apoptosis pathway, providing new theoretical basis for clinical application of MTH treatment for MI/RI.

Publisher

Research Square Platform LLC

Reference32 articles.

1. Global Health Estimates. 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000–2016. Geneva, Switzerland: World Health Organization; 2018.

2. Myocardial infarction: symptoms and treatments;Lu L;Cell Biochem Biophys,2015

3. Myocardial ischemia-reperfusion injury: a neglected therapeutic target;Hausenloy DJ;J Clin Invest,2013

4. The failing heart—an engine out of fuel;Neubauer S;N Engl J Med,2007

5. Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury;Morciano G;J Mol Cell Cardiol,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3